Efficacy of laser CO2 treatment for refractory lymphedema secondary to cancer treatments.
Lasers Surg Med
; 54(3): 337-341, 2022 03.
Article
em En
| MEDLINE
| ID: mdl-34837392
ABSTRACT
Lymphedema is a frequent debilitating condition among cancer patients. Daily supportive treatment may be necessary without long-term improvement. We describe two cases with chronic refractory lymphedema treated with fractional 10,600 nm CO2 laser. A 61-year-old female with locally advanced cervical cancer presented with postsurgical edematous swelling of the vulva and mons pubis and recurring cellulitis due to chronic lymphangiectasia. After six treatments of fractional CO2 laser, she noticed an 80% reduction of lymphorrea, swelling, and frequency of cellulitis. A 32-year old melanoma patient presented with refractory right lower leg lymphedema post right inguinal lymph node dissection and radiation. After fractional CO2 laser, she noted increased softness of her inguinal scar and a decrease of the lower leg edema. Fractional CO2 laser may be useful in addressing chronic refractory lymphedema. Further research should confirm our findings to consider fractional laser as a standard method in the treatment of chronic lymphedema.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Lasers de Gás
/
Linfedema
/
Melanoma
Tipo de estudo:
Etiology_studies
Limite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Lasers Surg Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos